Prediction and identification of B cell epitopes using protein sequence and structure information

Computational Structural Biology: Methods and Applications

Volumn , Issue , 2008, Pages 425-443

  Andersen, P ^a   Mkhailov, D ^b   Lund, O ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; PROTEIN SEQUENCES; STRUCTURE INFORMATION;

EID: 84969175301     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812778789_0015     Document Type: Chapter

References (67)

1. Paul WE. (2003) Fundamental Immunology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, USA.
2. Lo Passo C, Romeo A, Pernice I, et al. (2007) Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization. J Immunol 178: 4417-4423.
3. Van Regenmortel MHV. (1996) Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity. Methods 9: 465-472.
4. Barlow DJ, Edwards MS, Thornton JM. (1986) Continuous and discontinuous protein antigenic determinants. Nature 322: 747-748.
5. Thornton JM, Edwards MS, Taylor WR, Barlow DJ. (1986) Location of "continuous" antigenic determinants in the protruding regions of proteins. EMBO J 5: 409-413.
6. Andersen P, Nielsen M, Lund O. (2006) Prediction of residues in discontinuous B cell epitopes using protein 3D structures. Protein Sci 15: 2558-2567.
7. Novotny J, Handschumacher M, Haber E, et al. (1986) Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc Natl Acad Sci USA 83: 226-230.
8. Lund O, Nielsen M, Lundegaard C, Kesmir C, Brunak S. (2005) Immunological Bioinformatics (Computational Molecular Biology), 1st ed. MIT Press, Cambridge, Massachusetts.
9. Hopp TP, Woods KR. (1983) A computer program for predicting protein antigenic determinants. Mol Immunol 20: 483-489.
10. Korber B, LaBute M, Yusim K. (2006) Immunoinformatics comes of age. PLoS Comput Biol 2: E71.
11. Parker JM, Guo D, Hodges RS. (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25(19): 5425-5432.
12. Kyte J, Doolittle RF. (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
13. Welling GW, Weijer WJ, van der Zee R, Welling WS. (1985) Prediction of sequential antigenic regions in proteins. FEBS Lett 188: 215-218.
14. Chothia, C. (1976) The nature of the accessible and buried surfaces in proteins. J Mol Biol 105 (1): 1-12.
15. Janin J, Wodak S. (1978) Conformation of amino acid side-chains in proteins. J Mol Biol 125: 357-386.
16. Emini EA, Hughes JV, Perlow DS, Boger J. (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55: 836-839.
17. Karplus PA, Schulz GE (1985) Prediction of chain flexibility in proteins: a tool for the selection of peptide antigens. Naturwissenschaften 72: 212-213.
18. Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47: 45-148.
19. Garnier J, Osguthorpe DJ, Robson B. (1978) Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 120: 97-120.
20. Pellequer JL, Westhof E (1993) PREDITOP: a program for antigenicity prediction. J Mol Graph 11(3): 204-210.
21. Bairoch A, Apweiler R. (2000) The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucl Acids Res 28: 45-48.
22. Pellequer JL, Westhof E, Van Regenmortel MH. (1991) Predicting location of continuous epitopes in proteins from their primary structures. Meth Enzymol 203: 176-201.
23. Alix AJ. (1999) Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine 18: 311-314.
24. Jameson BA, Wolf H. (1988) The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 4: 181-186.
25. Kolaskar AS, Tongaonkar PC. (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276: 172-174.
26. Maksyutov AZ, Zagrebelnaya ES. (1993) ADEPT: a computer program for prediction of protein antigenic determinants. Comput Appl Biosci 9: 291-297.
27. Pellequer JL, Westhof E. (1993) PREDITOP: a program for antigenicity prediction. J Mol Graph 11: 204-210.
28. Blythe MJ, Flower DR (2005) Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci 14: 246-248.
29. Saha S, Bhasin M, Raghava GPS. (2005) Bcipep: a database of B cell epitopes. BMC Genom 6: 79.
30. Saha S, Raghava GPS. (2006) Prediction of continuous B cell epitopes in an antigen using recurrent neural network. Proteins 65: 40-48.
31. Larsen JEP, Lund O, Nielsen M. (2006) Improved method for predicting linear B cell epitopes. Immunome Res 2: 2.
32. Toseland CP, Clayton DJ, McSparron H, et al. (2005) AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res 1: 4.
33. Söllner J, Mayer B. (2006) Machine learning approaches for prediction of linear B cell epitopes on proteins. J Mol Recogn 19: 200-208.
34. Schonbach C, Koh JLY, Flower DR, Wong L, Brusic V. (2002) FIMM, a database of functional molecular immunology: update 2002. Nucl Acids Res 30: 226-229.
35. Guex N, Peitsch, MC. (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
36. Lee BK, Richards FM. (1971) The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55: 379-400.
37. Kulkarni-Kale U, Bhosle S, Kolaskar AS. (2005) CEP: a conformational epitope prediction server. Nucl Acids Res 33: 168-171.
38. Bai T, Becker M, Gupta A, et al. (2005) Structure of AMA1 from plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci USA 102: 12736-12741.
39. Pizarro JC, Vulliez B, Chesne SML, et al. (2005) Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 308: 408-411.
40. Coley AM, Parisi K, Masciantonio R, et al. (2006) The most polymorphic residue on plasmodium falciparum apical membrane antigen-1 determines binding of an invasion-inhibitory antibody. Infect Immunol 74: 2628-2636.
41. Batori V, Friis EP, Nielsen H, Roggen EL. (2006) An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context. J Mol Recogn 19: 21-29.
42. Rapberger R, Lukas A, Mayer B. (2007) Identification of discontinuous antigenic determinants on proteins based on shape complementarities. J Mol Recogn 20: 113-121.
43. Meloen RH, Puijk WC, Slootstra JW. (2000) Mimotopes: realization of an unlikely concept, J Mol Recogn 13: 352-359
44. Arnon R, Ben-Yedidia T. (2003) Old and new vaccine approaches. Int Immunopharmacol 3: 1195-1204.
45. Van Regenmortel MHV. (2007) The rational design of biological complexity: A deceptive metaphor. Proteomics 7: 965-975.
46. Ellis RW. (1999) New technologies for making vaccines. Vaccine 17: 1596-1604.
47. Ljubojevic S. (2006) The human papillomavirus vaccines. Acta Dermatovenerol Croat 14: 208.
48. Keating GM, Noble S. (2003) Recombinant hepatitis B vaccine (Engerix B): A review of its immunogenicity and protective efficacy against hepatitis B. Drugs 63: 1021-1051.
49. Douek DC, Kwong PD, Nabel GJ. (2006) The rational design of an AIDS vaccine. Cell 124: 677-681.
50. Heppner DGJ, Kester KE, Ockenhouse CF, et al. (2005) Towards an RTS, S-based, multistage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23: 2243-2250.
51. Matuschewski K. (2006) Vaccine development against malaria. Curr Opin Immunol 18: 449-457.
52. Hamby CV, Llibre M, Utpat S, Wormser GP. (2005) Use of peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera. Clin Diagn Lab Immunol 12: 801-807.
53. Hsueh, PR, Kao CL, Lee CN, et al. (2004) SARS antibody test for serosurveillance. Emerg Infect Dis 10: 1558-1562.
54. Mahler M, Bluthner M, Pollard KM. (2003) Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Clin Immunol 107: 65-79.
55. Selak S, Mahler M, Miyachi K, Fritzler ML, Fritzler MJ. (2003) Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1). Clin Immunol 109: 154-164.
56. Eigenmann PA. (2004) Do we have suitable in vitro diagnostic tests for the diagnosis of food allergy? Curr Opin Allergy Clin Immunol 4: 211-213.
57. Valmori D, Souleimanian NE, Hesdorer CS, et al. (2005) Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses. Clin Immunol 117: 24-30.
58. Sabhnani L, Manocha M, Sridevi K, et al. (2003) Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles. FEMS Immunol Med Microbiol 38: 215-229.
59. Cabezas E, Wang M, Parren PW, Stanfield RL, Satterthwait AC. (2000) A structure-based approach to a synthetic vaccine for HIV-1. Biochemistry 39: 14377-14391.
60. Sabo JK, Keizer DW, Feng ZP, et al. (2007) Mimotopes of apical membrane antigen-1: structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue. Infect Immun 75: 61-73.
61. Hans D, Young PR, Fairlie DP. (2006) Current status of short synthetic peptides as vaccines. Med Chem 2: 627-646.
62. Zhang YL, Guo YL, Wang KY, et al. (2007) Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 65: 320-328.
63. Saphire EO, Montero M, Menendez A, et al. (2007) Structure of a high-a.nity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. J Mol Biol 369: 696-709.
64. Untersmayr E, Szalai K, Riemer AB, et al. (2006) Mimotopes identify conformational epitopes on parvalbumin, the major.sh allergen. Mol Immunol 43: 1454-1461.
65. Koide S, Yang X, Huang X, Dunn JJ, Luft BJ. (2005) Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. J Mol Biol 350: 290-299.
66. Zhou T, Xu L, Dey B, et al. (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445: 732-737.
67. Greenbaum JA, Andersen PH, Blythe M, et al. (2007) Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recogn 20: 75-82.